Ideaya Biosciences

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$10,876
$207,834
$0
$0
Gross Profit
9,679
206,804
-1,233
-1,133
EBITDA
-93,373
120,274
-76,258
-71,045
EBIT
-94,570
119,244
-77,491
-72,178
Net Income
-83,273
119,244
-77,491
-72,178
Net Change In Cash
10,876
207,834
0
0
Free Cash Flow
-90,829
142,172
-63,137
-61,672
Cash
112,825
298,927
114,645
129,996
Basic Shares
88,582
89,690
88,472
88,356

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$218,710
$7,000
$23,385
$50,931
Gross Profit
214,117
3,166
19,377
50,931
EBITDA
-154,720
-270,643
-108,953
-60,401
EBIT
-159,313
-274,477
-112,961
-62,502
Net Income
-113,698
-274,477
-112,961
-54,808
Net Change In Cash
218,710
7,000
23,385
50,931
Cost of Revenue
-23,414
Free Cash Flow
-73,466
-251,441
-117,592
-90,618
Cash
112,825
84,378
157,018
68,632
Basic Shares
88,485
81,678
57,519
41,444

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.94
2025-09-30
$1.33
2025-06-30
-$0.88